{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:15:49Z","timestamp":1781576149591,"version":"3.54.5"},"reference-count":97,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/femspd\/ftz003","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T04:21:48Z","timestamp":1547612508000},"source":"Crossref","is-referenced-by-count":8,"title":["Focused dengue vaccine development: outwitting nature's design"],"prefix":"10.1093","volume":"77","author":[{"given":"Stephan T","family":"Kudlacek","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Biophysics, University of North Carolina, 125 Mason Farm Road, 6230E Marisco Hall, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan W","family":"Metz","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of North Carolina, 125 Mason Farm Road, 6230E Marisco Hall, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"key\n\t\t\t\t2019030119203827200_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14760584.2017.1276831","article-title":"Consider stopping dengvaxia administration without immunological screening","volume":"16","author":"Aguiar","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t2019030119203827200_bib3","doi-asserted-by":"crossref","first-page":"e0005179","DOI":"10.1371\/journal.pntd.0005179","article-title":"The impact of the newly licensed dengue vaccine in endemic countries","volume":"10","author":"Aguiar","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1473-3099(17)30752-1","article-title":"Dengvaxia: age as surrogate for serostatus","volume":"18","author":"Aguiar","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib4","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1021\/acs.jctc.7b00125","article-title":"The rosetta all-atom energy function for macromolecular modeling and design","volume":"13","author":"Alford","year":"2017","journal-title":"J Chem Theory Comput"},{"key":"key\n\t\t\t\t2019030119203827200_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2019030119203827200_bib6","first-page":"189","article-title":"Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers","volume":"65","author":"Bhamarapravati","year":"1987","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2019030119203827200_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019030119203827200_bib8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/sj.emboj.7600064","article-title":"Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation","volume":"23","author":"Bressanelli","year":"2004","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t2019030119203827200_bib9","doi-asserted-by":"crossref","first-page":"14349","DOI":"10.1074\/jbc.M117.784165","article-title":"Computational tools help improve protein stability but with a solubility tradeoff","volume":"292","author":"Broom","year":"2017","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019030119203827200_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nprot.2006.94","article-title":"Isolating and engineering human antibodies using yeast surface display","volume":"1","author":"Chao","year":"2006","journal-title":"Nat Protoc"},{"key":"key\n\t\t\t\t2019030119203827200_bib11","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"Cherrier","year":"2009","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t2019030119203827200_bib12","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.vaccine.2010.01.022","article-title":"Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys","volume":"28","author":"Clements","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acs.bioconjchem.8b00090","article-title":"Optimization of surface display of DENV2 E protein on a nanoparticle to induce virus specific neutralizing antibody responses","volume":"29","author":"Coffman","year":"2018","journal-title":"Bioconjug Chem"},{"key":"key\n\t\t\t\t2019030119203827200_bib14","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1016\/j.vaccine.2011.07.021","article-title":"The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease","volume":"29","author":"Coller","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.clinthera.2017.07.001","article-title":"Progress and works in progress: update on flavivirus vaccine development","volume":"39","author":"Collins","year":"2017","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t2019030119203827200_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019030119203827200_bib17","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"de\u00a0Alwis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019030119203827200_bib19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t2019030119203827200_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t2019030119203827200_bib18","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1128\/JVI.00224-12","article-title":"Mutagenesis of the DI\/DIII linker in dengue virus envelope protein impairs viral particle assembly","volume":"86","author":"de\u00a0Wispelaere","year":"2012","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019030119203827200_bib21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/jiw067","article-title":"A 12-month-interval dosing study in adults indicates that a single dose of the national institute of allergy and infectious diseases tetravalent dengue vaccine induces a robust neutralizing antibody response","volume":"214","author":"Durbin","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrg2146","article-title":"The distribution of fitness effects of new mutations","volume":"8","author":"Eyre-Walker","year":"2007","journal-title":"Nat Rev Genet"},{"key":"key\n\t\t\t\t2019030119203827200_bib23","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","volume":"102","author":"Fahimi","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"key":"key\n\t\t\t\t2019030119203827200_bib24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1097-2765(01)00206-4","article-title":"Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus","volume":"7","author":"Ferlenghi","year":"2001","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t2019030119203827200_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"key\n\t\t\t\t2019030119203827200_bib26","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1128\/JVI.00757-13","article-title":"Structural changes in dengue virus when exposed to a temperature of 37 degrees C","volume":"87","author":"Fibriansah","year":"2013","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019030119203827200_bib28","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t2019030119203827200_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","article-title":"A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface","volume":"6","author":"Fibriansah","year":"2014","journal-title":"EMBO Mol Med"},{"key":"key\n\t\t\t\t2019030119203827200_bib29","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1371\/journal.pntd.0003749","article-title":"The complexity of a dengue vaccine: a review of the human antibody response","volume":"9","author":"Flipse","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib30","doi-asserted-by":"crossref","first-page":"e00380","DOI":"10.1128\/mSphere.00380-16","article-title":"Epitope addition and ablation via manipulation of a dengue virus serotype 1 infectious clone","volume":"2","author":"Gallichotte","year":"2017","journal-title":"mSphere"},{"key":"key\n\t\t\t\t2019030119203827200_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.18433\/J3PC80","article-title":"Enhanced prokaryotic expression of dengue virus envelope protein","volume":"16","author":"Ganguly","year":"2013","journal-title":"J Pharm Pharm Sci"},{"key":"key\n\t\t\t\t2019030119203827200_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymeth.2012.03.014","article-title":"Protein selection using yeast surface display","volume":"60","author":"Gera","year":"2013","journal-title":"Methods"},{"key":"key\n\t\t\t\t2019030119203827200_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019030119203827200_bib34","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.vaccine.2015.06.067","article-title":"Preclinical development of a dengue tetravalent recombinant subunit vaccine: immunogenicity and protective efficacy in nonhuman primates","volume":"33","author":"Govindarajan","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib35","doi-asserted-by":"crossref","first-page":"19296","DOI":"10.1073\/pnas.1006528107","article-title":"Engineering a protein-protein interface using a computationally designed library","volume":"107","author":"Guntas","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019030119203827200_bib36","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t2019030119203827200_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019030119203827200_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/erv.09.139","article-title":"Domain III of the envelope protein as a dengue vaccine target","volume":"9","author":"Guzman","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t2019030119203827200_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019030119203827200_bib40","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","article-title":"Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age","volume":"35","author":"Halstead","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib42","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/elps.201500186","article-title":"Development of a capillary zone electrophoresis method for dose determination in a tetravalent dengue vaccine candidate","volume":"36","author":"Hamm","year":"2015","journal-title":"Electrophoresis"},{"key":"key\n\t\t\t\t2019030119203827200_bib43","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib44","doi-asserted-by":"crossref","first-page":"E8378","DOI":"10.1073\/pnas.1714250115","article-title":"Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials","volume":"115","author":"Juraska","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019030119203827200_bib45","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1021\/bi902153g","article-title":"Practically useful: what the Rosetta protein modeling suite can do for you","volume":"49","author":"Kaufmann","year":"2010","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t2019030119203827200_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4269\/ajtmh.16-0503","article-title":"Recombinant dengue virus 4 envelope glycoprotein virus-like particles derived from pichia pastoris are capable of eliciting homotypic domain III-directed neutralizing antibodies","volume":"96","author":"Khetarpal","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2019030119203827200_bib47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/infdis\/jiv082","article-title":"Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults","volume":"212","author":"Kirkpatrick","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib48","doi-asserted-by":"crossref","first-page":"330ra336","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"Kirkpatrick","year":"2016","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2019030119203827200_bib49","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1074\/jbc.RA118.002658","article-title":"Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins","volume":"293","author":"Kudlacek","year":"2018","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019030119203827200_bib50","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.virol.2015.03.025","article-title":"Shake, rattle, and roll: impact of the dynamics of flavivirus particles on their interactions with the host","volume":"479\u2013480","author":"Kuhn","year":"2015","journal-title":"Virology"},{"key":"key\n\t\t\t\t2019030119203827200_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nbt.2797","article-title":"Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface","volume":"32","author":"Lewis","year":"2014","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t2019030119203827200_bib52","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t2019030119203827200_bib53","doi-asserted-by":"crossref","first-page":"14339","DOI":"10.1038\/ncomms14339","article-title":"Conformational changes in intact dengue virus reveal serotype-specific expansion","volume":"8","author":"Lim","year":"2017","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t2019030119203827200_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/emi.2016.74","article-title":"Vaccines and immunization strategies for dengue prevention","volume":"5","author":"Liu","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"key\n\t\t\t\t2019030119203827200_bib55","first-page":"335","article-title":"Expression of tick-borne encephalitis virus prM-E protein in insect cells and studies on its antigenicity","volume":"19","author":"Liu","year":"2005","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"key\n\t\t\t\t2019030119203827200_bib56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12866-014-0233-3","article-title":"Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t2019030119203827200_bib57","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.06072-11","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019030119203827200_bib58","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2012.08.023","article-title":"Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering","volume":"30","author":"Mamo","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib59","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1016\/j.vaccine.2015.09.101","article-title":"Preclinical and clinical development of a dengue recombinant subunit vaccine","volume":"33","author":"Manoff","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib60","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1038\/s41598-017-04767-6","article-title":"In vitro assembly and stabilization of dengue and zika virus envelope protein homo-dimers","volume":"7","author":"Metz","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019030119203827200_bib61","doi-asserted-by":"crossref","first-page":"e0006793","DOI":"10.1371\/journal.pntd.0006793","article-title":"Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype","volume":"12","author":"Metz","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib62","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1371\/journal.pntd.0005071","article-title":"Precisely molded nanoparticle displaying DENV-E proteins induces robust serotype-specific neutralizing antibody responses","volume":"10","author":"Metz","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib63","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019030119203827200_bib64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019030119203827200_bib65","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/JVI.79.2.1223-1231.2005","article-title":"Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein","volume":"79","author":"Modis","year":"2005","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019030119203827200_bib66","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t2019030119203827200_bib69","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1016\/j.vaccine.2015.11.022","article-title":"Development of a recombinant, chimeric tetravalent dengue vaccine candidate","volume":"33","author":"Osorio","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030119203827200_bib70","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1473-3099(14)70811-4","article-title":"Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study","volume":"14","author":"Osorio","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrg3927","article-title":"Methods for the directed evolution of proteins","volume":"16","author":"Packer","year":"2015","journal-title":"Nat Rev Genet"},{"key":"key\n\t\t\t\t2019030119203827200_bib72","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/S1473-3099(16)30471-6","article-title":"Prevention and control of dengue-the light at the end of the tunnel","volume":"17","author":"Pang","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019030119203827200_bib73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-virology-031413-085453","article-title":"Vaccine development as a means to control dengue virus pathogenesis: do we know enough?","volume":"1","author":"Pierson","year":"2014","journal-title":"Annu Rev Virol"},{"key":"key\n\t\t\t\t2019030119203827200_bib74","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/embor.2011.75","article-title":"Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres","volume":"12","author":"Plevka","year":"2011","journal-title":"EMBO Rep"},{"key":"key\n\t\t\t\t2019030119203827200_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12896-016-0280-y","article-title":"Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies","volume":"16","author":"Poddar","year":"2016","journal-title":"BMC Biotechnol"},{"key":"key\n\t\t\t\t2019030119203827200_bib76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15252\/embr.201745302","article-title":"The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep"},{"key":"key\n\t\t\t\t2019030119203827200_bib77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tibs.2016.03.002","article-title":"Protein engineering by combined computational and in vitro evolution approaches","volume":"41","author":"Rosenfeld","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"key\n\t\t\t\t2019030119203827200_bib78","doi-asserted-by":"crossref","first-page":"15411","DOI":"10.1038\/ncomms15411","article-title":"Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope","volume":"8","author":"Rouvinski","year":"2017","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t2019030119203827200_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019030119203827200_bib80","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t2019030119203827200_bib81","volume-title":"Seperation Process Principles","author":"Seader","year":"2006"},{"key":"key\n\t\t\t\t2019030119203827200_bib82","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/pro.8","article-title":"RosettaHoles: rapid assessment of protein core packing for structure prediction, refinement, design, and validation","volume":"18","author":"Sheffler","year":"2009","journal-title":"Protein Sci"},{"key":"key\n\t\t\t\t2019030119203827200_bib83","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41598-017-01097-5","article-title":"Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells","volume":"7","author":"Slon\u00a0Campos","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019030119203827200_bib84","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies","volume":"45","author":"Steichen","year":"2016","journal-title":"Immunity"},{"key":"key\n\t\t\t\t2019030119203827200_bib85","doi-asserted-by":"crossref","first-page":"20562","DOI":"10.1073\/pnas.1115124108","article-title":"Computational design of a symmetric homodimer using beta-strand assembly","volume":"108","author":"Stranges","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019030119203827200_bib86","doi-asserted-by":"crossref","first-page":"139ra183","DOI":"10.1126\/scitranslmed.3003888","article-title":"The structural basis for serotype-specific neutralization of dengue virus by a human antibody","volume":"4","author":"Teoh","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2019030119203827200_bib87","first-page":"238","article-title":"Evaluation of Japanese B encephalitis vaccine. IV. pattern of serologie response to vaccination over a five-year period in an endemic area (Okayama, Japan)","volume":"63","author":"Tigertt","year":"1956","journal-title":"American Journal of Hygiene"},{"key":"key\n\t\t\t\t2019030119203827200_bib88","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3389\/fimmu.2018.01919","article-title":"Recent developments in recombinant protein-based dengue vaccines","volume":"9","author":"Tripathi","year":"2018","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t2019030119203827200_bib89","doi-asserted-by":"crossref","first-page":"e01181","DOI":"10.1128\/JVI.01181-17","article-title":"Envelope-modified tetravalent dengue virus-like particle vaccine: implication for flavivirus vaccine design","volume":"91","author":"Urakami","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019030119203827200_bib90","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The human antibody response to dengue virus infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses"},{"key":"key\n\t\t\t\t2019030119203827200_bib91","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1021\/ac086009h","article-title":"The promise of phage display: customized affinity and specificity","volume":"80","author":"Weiss","year":"2008","journal-title":"Anal Chem"},{"key":"key\n\t\t\t\t2019030119203827200_bib92","doi-asserted-by":"crossref","first-page":"17169","DOI":"10.1038\/s41598-017-17355-5","article-title":"Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4","volume":"7","author":"Widman","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019030119203827200_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1742-4658.2007.06178.x","article-title":"Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures","volume":"275","author":"Wlodawer","year":"2008","journal-title":"FEBS J"},{"key":"key\n\t\t\t\t2019030119203827200_bib68","year":"2018"},{"key":"key\n\t\t\t\t2019030119203827200_bib94","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10930-007-9108-x","article-title":"Characterization of protein-protein interfaces","volume":"27","author":"Yan","year":"2008","journal-title":"Protein J"},{"key":"key\n\t\t\t\t2019030119203827200_bib95","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.1304300110","article-title":"Dengue structure differs at the temperatures of its human and mosquito hosts","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019030119203827200_bib96","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2015.04.006","article-title":"Temperature dependent conformational change of dengue virus","volume":"12","author":"Zhang","year":"2015","journal-title":"Curr Opin Virol"},{"key":"key\n\t\t\t\t2019030119203827200_bib97","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.str.2004.06.019","article-title":"Conformational changes of the flavivirus E glycoprotein","volume":"12","author":"Zhang","year":"2004","journal-title":"Structure"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/77\/1\/ftz003\/28002502\/ftz003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T03:36:54Z","timestamp":1720928214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article\/doi\/10.1093\/femspd\/ftz003\/5307883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,2,6]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/femspd\/ftz003","relation":{},"ISSN":["2049-632X"],"issn-type":[{"value":"2049-632X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2019,2,1]]}}}